Peterborough

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria1 trial
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• Stroke1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Novartis Pharmaceuticals2 trials

Running trials

• Active, not recruiting

  24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

  NCT05677451· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source